Thoughtful thread on advisability of mRNA booster after J&J vaccine as Delta invariably increases here.
Already boosters are being done on a case-by-case basis, and its not hard to understand why.
Too soon for a policy statement?
(h/t @zeynep)https://twitter.com/michaelzlin/status/1407059999101181955 …
-
-
I’ve a NYT piece arguing prioritize vulnerable groups and healthcare workers globally even if it means slower rollout especially to less vulnerable, but real solution is increasing supply—to remove the dilemma. Still, symptomatic breakthrough could transmit. Needs assessment.
-
To me it’s like the question over vaccinating teenagers. “Should we do it” is a correct broad question deserving discussion as well as “should we do it now given supply globally.” Anyway, I think clinicians needs CDC guidance! I don’t doubt they’re being asked.
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.